Sequence analysis of T-cell receptor participating in rejection of renal allografts.

参与同种肾移植排斥的T细胞受体的序列分析。

基本信息

  • 批准号:
    02670718
  • 负责人:
  • 金额:
    $ 0.58万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1992
  • 项目状态:
    已结题

项目摘要

In order to know what kind of T cell population participate in rejection of renal allografts, in this research project, I carried out sequence analysis of T-cell receptor cDNA expressed by renal infiltrating lymphocytes (RIL). First, I established the method for TCR sequence analysis, called Linker-Ligated PCR, in which synthetic anchor ligated at the upstream of TCR cDNA is utilized as target sequence for PCR-amplification. By utilizing the method established, I next analyzed TCR involved in recognition of HLA-DR molecules in mixed lymphocyte reaction (MLR), a in vitro model for allogeneic immune reaction. I found that diversity of TCR does not depend on the number of amino acid difference of DR molecules between responder and stimulator cells and even for a single amino acid difference of DR, enormously diverse set of TCR involved in MLR. Finally, I analyzed TCR in RIL isolated from rejected and nephrectomized allograft by treatment with collagenase and density-gradient centrifugation in Percoll. CD25^+(activated T marker) fraction was isolated and subjected to TCRbeta sequence analysis. Seven different Vbeta gene families and 8 Jbeta segments were detected among 31 cDNA clones sequenced. Several cDNA clones were found to have completely identical CDR3 sequences, i. e., 6 clones with Vbeta6.9-Jbeta1.2, 3 clones with Vbeta3.1-Jbeta2.1, 2 clones with Vbeta3.1-Jbeta2.7, 2 clones with Vbeta5.6-Jbeta2.5, 2 clones with Vbeta12b-Jbeta2.3. Considering that cDNA with identical CDR3 is rarely observed in the analysis of around 30 TCR cDNA clones obtained from in vitro MLR, CD25^+ RIL was thought to composed of T cell population expressing relatively limited TCR diversity.
为了了解什么样的T细胞群参与了移植肾排斥反应,本研究对肾脏浸润性淋巴细胞(RIL)表达的T细胞受体基因进行了序列分析。首先,我建立了一种TCR序列分析的方法,即连接在TCR基因上游的人工合成锚点作为靶序列进行聚合酶链式反应。利用所建立的方法,我接下来分析了在混合淋巴细胞反应(MLR)中参与识别人类白细胞抗原-DR分子的TCR,这是一种体外同种异体免疫反应模型。我发现TCR的多样性并不取决于应答细胞和刺激细胞之间DR分子的氨基酸差异的数量,甚至不取决于参与MLR的DR的单个氨基酸差异,这是一组差异巨大的TCR。最后,我用Percoll密度梯度离心法和胶原酶处理从排斥和肾切除的同种异体移植物中分离出RIL,分析了RIL的TCR。分离CD25^+(活化T标记)组分,进行TCRbeta序列分析。在31个克隆测序中,共检测到7个不同的Vbeta基因家族和8个Jbeta片段。有几个克隆的CDR3序列完全相同,即6个克隆Vbeta6.9-Jbeta1.2,3个克隆Vbeta3.1-Jbeta2.1,2个克隆Vbeta3.1-Jbeta2.7,2个克隆Vbeta5.6-Jbeta2.5,2个克隆Vbeta12b-Jbeta2.3。考虑到在从体外MLR获得的约30个TCR克隆中很少观察到具有相同CDR3的cDNA,CD25^+RIL被认为是由表达相对有限的TCR多样性的T细胞群组成的。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Obata F,Tsunoda M,Kaneko T,Ito K,Masewicz S,Mickelson EM,Ollier WER,Pawelec G,Cella M,et al.: "Human T-cell receptor TCRAV,TCRBV,and TCRAJ sequences newly found in T-cell clones reactive with allogeneic HLA-class II antignes." Immunogenetics.
Obata F,Tsunoda M,Kaneko T,Ito K,Masewicz S,Mickelson EM,Ollier WER,Pawelec G,Cella M,et al.:“在 T 细胞中新发现的人类 T 细胞受体 TCRAV、TCRBV 和 TCRAJ 序列
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe K, Yuge K, Sato K, Sonoda K, Masaki K, Maruyama S, Okubo M, Obata F, Otani F, Kaneko T, Takahara H, Matsubayashi T, Yago K, and Kashiwagi N: "Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with frac
Watanabe K、Yuge K、Sato K、Sonoda K、Masaki K、Maruyama S、Okubo M、Obata F、Otani F、Kaneko T、Takahara H、Matsubayashi T、Yago K 和 Kashiwagi N:“供体骨髓细胞促进诱导
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Obata F.,Ito K,Ito I,and Kashiwagi N: "Linkage between HLA-DRBI and -DRB3 types in the Japanese population analyzed by oligonucleotide genotyping." Human Immunology. 33. 284-288 (1992)
Obata F.、Ito K、Ito I 和 Kashiwagi N:“通过寡核苷酸基因分型分析日本人群中 HLA-DRBI 和 -DRB3 类型之间的关联。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe K.et al.: "Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506." Transplantation Proceedings. 23. 568-572 (1991)
Watanabe K. 等人:“供体骨髓细胞有助于诱导接受分次淋巴照射和 FK 506 治疗的狗对肾同种异体移植物的耐受性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Onda K,Obata F,Tsunoda M,Kato H,Ito I,Yang Yーg,& Kashiwagi N.: "Sequence analysis of Tーcell receptors used in allogeneic mixed lymphocyte reaction." Kitasato Archives of Experimental Medicine.
Onda K、Obata F、Tsunoda M、Kato H、Ito I、Yang Yg 和 Kashiwagi N.:“同种异体混合淋巴细胞反应中使用的 T 细胞受体的序列分析北里实验医学档案”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OBATA Fumiya其他文献

Analysis of immune responses in prostate cancer patients received low-dose-rate prostate brachyterapy
接受低剂量率前列腺近距离治疗的前列腺癌患者的免疫反应分析
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KUBO Makoto;SATOH Takefumi;ISHIYAMA Hiromichi;TABATA Ken-ichi;TSUMURA Yasuhide;IGARASHI Yasuyuki;IWAMURA Masatsugu;BABA Shiro;HAYAKAWA Kazushige;OBATA Fumiya
  • 通讯作者:
    OBATA Fumiya

OBATA Fumiya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OBATA Fumiya', 18)}}的其他基金

Health literacy of the child with mental disability
精神障碍儿童的健康素养
  • 批准号:
    23531287
  • 财政年份:
    2011
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clonality analysis of anti-HLA antibodies involved in chronic allograft rejection
参与慢性同种异体移植排斥的抗 HLA 抗体的克隆分析
  • 批准号:
    17591699
  • 财政年份:
    2005
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Comparative analysis of immune cells participating in acute and chronic rejection of kidney allografts.
免疫细胞参与同种肾移植急性和慢性排斥反应的比较分析。
  • 批准号:
    14571520
  • 财政年份:
    2002
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Psychological Research on Illness Denial of Alchoholics
酗酒者否认疾病的心理学研究
  • 批准号:
    13610113
  • 财政年份:
    2001
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the T-cell clonality in renal allografts using biopsy specimens.
使用活检标本分析肾同种异体移植物中的 T 细胞克隆性。
  • 批准号:
    09671649
  • 财政年份:
    1997
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DEVELOPMENT OF SELF-CARE BEHAVIOR OF CHRONICALLY ILL CHILDREN
慢性病儿童自我护理行为的培养
  • 批准号:
    07610110
  • 财政年份:
    1995
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the T-cell receptor expressed by renal allograft infiltrating cells
同种异体移植肾浸润细胞表达的T细胞受体分析
  • 批准号:
    06671613
  • 财政年份:
    1994
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Disruptive technologies for rapid detection of renal transplant rejection
快速检测肾移植排斥反应的颠覆性技术
  • 批准号:
    EP/Y036328/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Standard Grant
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
  • 批准号:
    10734277
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes
艾滋病毒捐献者的肾移植:对排斥和长期结果的影响
  • 批准号:
    10704333
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
Overcoming antibody-mediated rejection by regulating follicular T cells and memory B cells/plasma cells
通过调节滤泡 T 细胞和记忆 B 细胞/浆细胞克服抗体介导的排斥反应
  • 批准号:
    23K08048
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Left behind? Investigating the relationship between social exclusion, proposed triad of populist radical right attitudes and the rejection of perceive
被留下来?
  • 批准号:
    2887845
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
    Studentship
Endogenous memory T cell mediated rejection of high-risk cardiac allografts
内源性记忆T细胞介导的高风险同种异体心脏移植排斥反应
  • 批准号:
    10748492
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection
HLA-E限制性CD8调节性T细胞在肾同种异体移植排斥中的新作用
  • 批准号:
    10564689
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
A Multimethod Assessment of the Clinical, Economic & Social Impact of the Rejection of Federal HIV Prevention Funds in Tennessee
临床、经济的多方法评估
  • 批准号:
    10864276
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
A longitudinal and experience sampling investigation of rejection sensitivity and its role in sexual minority adolescents' mental health
拒绝敏感性及其在性少数青少年心理健康中的作用的纵向和经验抽样调查
  • 批准号:
    10656831
  • 财政年份:
    2023
  • 资助金额:
    $ 0.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了